98%
921
2 minutes
20
Chronic non-septic pleural effusion is a condition that frequently may occur because of lung or pleural neoplasia, or chylothorax refractory to surgical treatment, in dogs. Effusion management can be performed with multiple pleurocenteses or the application of chest drains. New modified vascular devices have been used for patients with chronic diseases; they offer the advantage of allowing home management and do not require hospitalization. Eight PleuralPort devices were applied in seven dogs during thoracoscopic exploration and biopsy procedures; five were affected by mesothelioma; one by lung metastases from a mammary carcinoma; and one by chronic chylothorax. The median time of surgical procedure was 51 min; one developed pneumothorax post-operatively that resolved within 12 h after repeated drainage; one device was obstructed after 45 days and was successfully managed by flushing. All patients were discharged after 24 h. The median duration of port insertion in cancer patients was 5 months and those dogs were euthanized because of tumor progression; in the dog with chylothorax, the device was removed after 1 year when the effusion had resolved.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223757 | PMC |
http://dx.doi.org/10.3390/vetsci10050324 | DOI Listing |
J Vasc Interv Radiol
September 2025
Interventional Radiology, University Hospital of Patras,Rio , Greece ,26504.
This study investigated the effects of Yttrium-90 (Y90) radioembolization in 8 rabbits, focusing on delivery accuracy, dosimetry, and pathological outcomes. Y90 was successfully delivered angiographically targeted via the pulmonary lower basal segmental arteries to all rabbits, with confirmation via PET/CT imaging and a lung target median of the mean dose 132.1Gy (range, 11.
View Article and Find Full Text PDFPediatr Blood Cancer
September 2025
Department of Radiation Oncology, Centre Léon Bérard, Lyon, France.
Background And Purpose: Ewing sarcoma (ES) is the most prevalent malignant thoracic tumor in childhood and young adults. This study reports the outcome of a national cohort treated in an international prospective trial for a localized rib ES, with a long follow-up.
Material And Methods: All the patients treated in a prospective trial (December 1999-April 2013) were included.
PLoS One
September 2025
Western Gipuzkoa Clinical Research Unit, Osakidetza/Basque Health Service, Mendaro Hospital, Gipuzkoa, Spain.
Objective: To perform an external validation of a previously reported machine learning (ML) approach for predicting the diagnosis of pleural tuberculosis.
Patients And Methods: We defined two cohorts: a Training group, comprising 273 out of 1,220 effusions from our prospective study (2013-2022); and a Testing group, from a retrospective analysis of 360 effusions from 832 consecutive patients in Bajo Deba health district (1996-2012). All the effusions included were exudative and lymphocytic.
J Surg Case Rep
September 2025
Department of Peritonectomy and Liver Surgery, St George Hospital, W.R. Pitney Building, Chapel Street, Kogarah, NSW 2217, Sydney, NSW, Australia.
Bilothorax is a rare and under-recognized complication of hepatobiliary interventions, especially cytoreductive surgeries and is associated with increased length of hospitalization, morbidity and mortality. There are ˂100 reported cases in the literature, and due to its rarity, no standardized diagnostic tests or treatment guidelines are currently available. We present a 58-year-old otherwise healthy woman with a history of recurrent ovarian cancer who underwent cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy with curative intent.
View Article and Find Full Text PDFCureus
August 2025
Family Medicine, Chino Valley Medical Center, Chino, USA.
This case presents a 25-year-old Indian male with no significant past medical history presenting to the emergency department (ED) due to two weeks of productive cough with pleuritic chest pain. The patient presented one week earlier to the ED; however, he left against medical advice and was given a 5-day course of Azithromycin 250 mg that minimally improved his symptoms. He returned to the ED shortly after completing the antibiotics and was admitted for further evaluation.
View Article and Find Full Text PDF